Clinical Trial: MINRIN® Orally Disintegrating Tablet (Fast Dissolving Desmopressin) and Tablets in Treatment of Primary Nocturnal Enuresis
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: MINRIN® Orally Disintegrating Tablet (Fast Dissolving Desmopressin) and Tablets in Treatment of Primary Nocturnal Enuresis With Special Focus on Patient Satisfaction
Brief Summary: Desmopressin in treatment of nocturnal enuresis (bedwetting).
Detailed Summary:
Sponsor: Ferring Pharmaceuticals
Current Primary Outcome: Assessment of patient and parent satisfaction [ Time Frame: 3 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Number of wet nights [ Time Frame: 3 months ]
- Assessment of drinking volume [ Time Frame: 3 months ]
- Assessment of urine volume [ Time Frame: 3 months ]
- Assessment of patient compliance [ Time Frame: 3 months ]
Original Secondary Outcome: Same as current
Information By: Ferring Pharmaceuticals
Dates:
Date Received: June 7, 2011
Date Started: June 2011
Date Completion:
Last Updated: June 11, 2013
Last Verified: June 2013